In a report released on February 5, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with ...

GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

CFRA analyst Wan Nurhayati revised the price target for GlaxoSmithKline (NYSE:GSK) shares, reducing it to $40.00 from the ...

GlaxoSmithKline plc (NYSE: NYSE:GSK) shares gained 5.65% after the pharmaceutical giant reported fourth quarter revenue that beat analyst estimates, despite earnings falling short of expectations.

American depositary shares of GSK jumped more than 8% Wednesday after the drugmaker reported better-than-expected quarterly results and boosted its long-term sales forecast. Sales of vaccines against ...

GlaxoSmithKline (GSK) has firmly acquired the number one position in the Egyptian pharmaceutical market since 2009 and is likely to maintain the grip at least until the end of 2011. GSK’s ...

GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue ... As on 31-12-2024, the company has a total of 16.94 Crore shares outstanding.GSK Pharma Share Price Today is Rs. 1960.40. On previous day, ...

Teva Pharmaceutical Industries Ltd. ADR-0.62% $20.28B ...

GlaxoSmithKline chief executive Emma Walmsley ... The US hedge fund, run by billionaire Paul Singer, has bought a sizeable stake in GSK thanks to in part to its slumping share price in recent ...

is Rs 1842.05 Glaxosmithkline Pharmaceuticals Ltd, incorporated in the year 1924, has its registered office in GSK House, Dr Annie Besant Road Worli, Mumbai, Maharashtra, 400030, 91-022-24959595 ...